Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Venaxis Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

18 Apr 2014 Reuters Investment Profile 12 $20.00

Venaxis Inc

19 Apr 2014 S&P Capital IQ Quantitative Report 11 $127.00

ASPENBIO PHARMA INC (APPY) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

19 Apr 2014 Pechala's Reports 1 $15.00

Thomson Reuters Stock Report - VENAXIS INC (APPY-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

18 Apr 2014 Thomson Reuters Stock Report 11 $25.00

APPY: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

18 Apr 2014 New Constructs, LLC 5 $25.00

Value Graph: VENAXIS -- APPY

17 Apr 2014 Ford Investor Services, Inc. 1 $12.00

"The Economy Matters" Report for APPY: the economy's impact on APPY's price and risk, featuring the powerful Economic Climate Rating

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating. Based on a sophisticated econometric framewor...

15 Apr 2014 MacroRisk Analytics/EconomicInvestor 7 $25.00

Venaxis, Inc. (APPY) - Financial and Strategic SWOT Analysis Review

Venaxis, Inc. (APPY) - Financial and Strategic SWOT Analysis Review Summary Venaxis, Inc. (Venaxis), formerly AspenBio Pharma...

10 Apr 2014 GlobalData 38 $125.00

TheStreet.com Ratings Stock Report For: VENAXIS INC (APPY)

06 Apr 2014 TheStreet.com Ratings 5 $10.00

Wright Investors Service Comprehensive Report for AspenBio Pharma, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

02 Apr 2014 Wright Reports 42 $75.00